» Articles » PMID: 37511644

Measures of Patient-Reported Expectations, Acceptance, and Satisfaction Using Automated Insulin Delivery Systems: A Review

Abstract

In people with type 1 diabetes, Automated Insulin Delivery (AID) systems adjust insulin delivery in response to sensor glucose data and consist of three components: an insulin pump, a continuous glucose sensor, and an algorithm that determines insulin delivery. To date, all the available AID systems require users to announce carbohydrate intake and deliver meal boluses, as well as respond to system alarms. The use of AID devices both initially and over time may be influenced by a variety of psychological factors. Analysis of patient-related outcomes should be taken into account, while recruiting applicants for the systems who are motivated and have realistic expectations in order to prevent AID dropout. We report an up-to-date summary of the available measures and semi-structured interview content to assess AID expectations, acceptance, and satisfaction using the AID systems. In conclusion, we suggest, before and after starting using AID systems, performing a specific evaluation of the related psychological implications, using validated measures and semi-structured interviews, that allows diabetes care providers to tailor their education approach to the factors that concern the patient at that time; they can teach problem-solving skills and other behavioral strategies to support sustained use of the AID system.

Citing Articles

Enhancing the Capabilities of Continuous Glucose Monitoring With a Predictive App.

Herrero P, Andorra M, Babion N, Bos H, Koehler M, Klopfenstein Y J Diabetes Sci Technol. 2024; 18(5):1014-1026.

PMID: 39158994 PMC: 11418465. DOI: 10.1177/19322968241267818.


Future acceptance of automated insulin delivery systems in youths with type 1 diabetes: validation of the Italian artificial pancreas-acceptance measure.

Franceschi R, Pertile R, Marigliano M, Mozzillo E, Maffeis C, Zaffani S Acta Diabetol. 2024; 62(2):177-183.

PMID: 39126517 PMC: 11861114. DOI: 10.1007/s00592-024-02327-9.


The Path From Awareness to Action: Exploring Diabetic Patients' Awareness and Attitudes and Barriers to Utilization of Artificial Pancreas in the Beheira Governorate, Egypt.

Hafez S, Mohammed N, Yahia Mahdy Shalby A, Eltaher Hamed Abdulrahman E, AlQarni A, Ayed Alhamami F Cureus. 2024; 16(1):e52703.

PMID: 38384620 PMC: 10879912. DOI: 10.7759/cureus.52703.

References
1.
Iturralde E, Tanenbaum M, Hanes S, Suttiratana S, Ambrosino J, Ly T . Expectations and Attitudes of Individuals With Type 1 Diabetes After Using a Hybrid Closed Loop System. Diabetes Educ. 2017; 43(2):223-232. PMC: 7162535. DOI: 10.1177/0145721717697244. View

2.
Bisio A, Brown S, McFadden R, Pajewski M, Yu P, DeBoer M . Sleep and diabetes-specific psycho-behavioral outcomes of a new automated insulin delivery system in young children with type 1 diabetes and their parents. Pediatr Diabetes. 2020; 22(3):495-502. DOI: 10.1111/pedi.13164. View

3.
Bevier W, Fuller S, Fuller R, Rubin R, Dassau E, Doyle 3rd F . Artificial pancreas (AP) clinical trial participants' acceptance of future AP technology. Diabetes Technol Ther. 2014; 16(9):590-5. PMC: 4135316. DOI: 10.1089/dia.2013.0365. View

4.
von dem Berge T, Remus K, Biester S, Reschke F, Klusmeier B, Adolph K . In-home use of a hybrid closed loop achieves time-in-range targets in preschoolers and school children: Results from a randomized, controlled, crossover trial. Diabetes Obes Metab. 2022; 24(7):1319-1327. DOI: 10.1111/dom.14706. View

5.
Gianini A, Suklan J, Skela-Savic B, Klemencic S, Battelino T, Dovc K . Patient reported outcome measures in children and adolescents with type 1 diabetes using advanced hybrid closed loop insulin delivery. Front Endocrinol (Lausanne). 2022; 13:967725. PMC: 9437950. DOI: 10.3389/fendo.2022.967725. View